Chronic HIV-1 viremia reverses NKG2A/NKG2C ratio on natural killer cells in patients with human cytomegalovirus co-infection

AIDS

Volumn 24, Issue 1, 2010, Pages 27-34

  Brunetta, Enrico ^a,b   Fogli, Manuela ^b   Varchetta, Stefania ^c   Bozzo, Luisa ^a   Hudspeth, Kelly L ^d   Marcenaro, Emanuela ^e   Moretta, Alessandro ^e   Mavilio, Domenico ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^c UNIVERSITY OF PAVIA   (Italy)

^d RUSH UNIVERSITY MEDICAL CENTER   (United States)

^e UNIVERSITY OF GENOA   (Italy)

Author keywords

Antiretroviral therapy; Biomarker; Human cytomegalovirus coinfection; Natural killer cell subsets; NKG2A NKG2C ratio

Indexed keywords

ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; NATURAL KILLER CELL RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; NATURAL KILLER CELL RECEPTOR NKG2C; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CELL EXPANSION; CHRONIC DISEASE; CYTOMEGALOVIRUS INFECTION; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; HUMAN CYTOMEGALOVIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MIXED INFECTION; NATURAL KILLER CELL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; VIREMIA; VIRUS REPLICATION;

CYTOMEGALOVIRUS INFECTIONS; FEMALE; FLOW CYTOMETRY; GENE EXPRESSION REGULATION, VIRAL; HIV INFECTIONS; HIV-1; HUMANS; KILLER CELLS, NATURAL; MALE; NK CELL LECTIN-LIKE RECEPTOR SUBFAMILY C; VIREMIA;

EID: 73649147373     PISSN: 02699370     EISSN: 14735571     Source Type: Journal    
DOI: 10.1097/QAD.0b013e3283328d1f     Document Type: Article

References (18)

1. Fauci AS, Mavilio D, Kottilil S. NK cells in HIV infection: paradigm for protection or targets for ambush. Nat Rev Immunol 2005; 5:835-843.
2. Iannello A, Debbeche O, Samarani S, Ahmad A. Antiviral NK cell responses in HIV infection: II. viral strategies for evasion and lessons for immunotherapy and vaccination. J Leukoc Biol 2008; 84:27-49.
3. Alter G, Altfeld M. NK cells in HIV-1 infection: evidence for their role in the control of HIV-1 infection. J Intern Med 2009; 265:29-42.
4. De Maria A, Moretta L. NK cell function in HIV-1 infection. Curr HIV Res 2008; 6:433-440.
5. Mavilio D, Benjamin J, Daucher M, Lombardo G, Kottilil S, Planta MA, et al. Natural killer cells in HIV-1 infection: dichot-omous effects of viremia on inhibitory and activating receptors and their functional correlates. Proc Natl Acad Sci U S A 2003; 100:15011-15016.
6. Mavilio D, Lombardo G, Benjamin J, Kim D, Follman D, Marcenaro E, et al. Characterization of CD56-/CD16R natural killer (NK) cells: a highly dysfunctional NK subset expanded in HIV-infected viremic individuals. Proc Natl Acad Sci U S A 2005; 102:2886-2891.
7. Vales-Gomez M, Reyburn HT, Erskine RA, Lopez-Botet M, Strominger JL. Kinetics and peptide dependency of the binding of the inhibitory NK receptor CD94/NKG2-A and the activating receptor CD94/NKG2-C to HLA-E. EMBO J 1999; 18:4250-4260.
8. Mela CM, Burton CT, ImamiN, NelsonM, Steel A, Gazzard BG, et al. Switch from inhibitory to activating NKG2 receptor expression in HIV-1 infection: lack of reversion with highly active antiretroviral therapy. AIDS 2005; 19:1761-1769.
9. Lanier LL, Corliss B, Wu J, Phillips JH. Association of DAP12 with activating CD94/NKG2C NK cell receptors. Immunity 1998; 8:693-701.
10. Guma M, Budt M, Saez A, Brckalo T, Hengel H, Angulo A, Lopez-Botet M. Expansion of CD94/NKG2CR NK cells in response to human cytomegalovirus-infected fibroblasts. Blood 2006; 107:3624-3631.
11. Guma M, Cabrera C, Erkizia I, Bofill M, Clotet B, Ruiz L, Lopez-Botet M. Human cytomegalovirus infection is associated with increased proportions of NK cells that express the CD94/ NKG2C receptor in aviremic HIV-1-positive patients. J Infect Dis 2006; 194:38-41.
12. Mela CM, Goodier MR. The contribution of cytomegalovirus to changes in NK cell receptor expression in HIV-1-infected individuals. J Infect Dis 2007; 195:158-159; author reply 159-160.
13. Migueles SA, Osborne CM, Royce C, Compton AA, Joshi RP, Weeks KA, et al. Lytic granule loading of CD8R T cells is required for HIV-infected cell elimination associated with immune control. Immunity 2008; 29:1009-1021.
14. Mavilio D, Benjamin J, Kim D, Lombardo G, DaucherM, Kinter A, et al. Identification of NKG2A and NKp80 as specific natural killer cell markers in rhesus and pigtailed monkeys. Blood 2005; 106:1718-1725.
15. Caligiuri MA. Human natural killer cells. Blood 2008; 112:461-469.
16. Pantazis N, Touloumi G, Vanhems P, Gill J, Bucher HC, Porter K. The effect of antiretroviral treatment of different durations in primary HIV infection. AIDS 2008; 22:2441-2450.
17. Zeger SL, Diggle PJ. Semiparametric models for longitudinal data with application to CD4 cell numbers in HIV serocon-verters. Biometrics 1994; 50:689-699.
18. Flo RW, Haukenes G, Nilsen A, Skjaerven R, Forsgren M, Fehniger TE. Longitudinal study of cytomegalovirus antibodies in individuals infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis 1995; 14:504-511.